Telomir Pharmaceuticals, Inc.
TELO
$1.45
-$0.05-3.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 754.30K | 403.00K | 1.27M | 834.60K | 1.88M |
| Total Receivables | -- | -- | -- | -- | 130.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 75.30K | 88.20K | 57.90K | 77.30K | 87.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 130.00K | -- |
| Total Current Assets | 829.60K | 491.20K | 1.32M | 1.04M | 2.10M |
|
|
|||||
| Total Current Assets | 829.60K | 491.20K | 1.32M | 1.04M | 2.10M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 829.60K | 491.20K | 1.32M | 1.04M | 2.10M |
|
|
|||||
| Total Accounts Payable | 255.00K | 558.90K | 587.50K | 506.50K | 393.80K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 93.40K | 93.40K | 93.40K | 93.40K | 140.30K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 348.40K | 652.30K | 681.00K | 599.90K | 534.20K |
|
|
|||||
| Total Current Liabilities | 348.40K | 652.30K | 681.00K | 599.90K | 534.20K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 93.40K | 93.40K | 93.40K | 93.40K | 140.30K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 348.40K | 652.30K | 681.00K | 599.90K | 534.20K |
|
|
|||||
| Common Stock & APIC | 38.33M | 32.62M | 31.24M | 28.14M | 23.34M |
| Retained Earnings | -37.85M | -32.78M | -30.60M | -27.70M | -21.77M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 481.20K | -161.10K | 643.00K | 442.10K | 1.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 481.20K | -161.10K | 643.00K | 442.10K | 1.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 481.20K | -161.10K | 643.00K | 442.10K | 1.57M |
|
|
|||||